Dillico announces the closing of a €7.5 million financing round to launch the commercialization of its innovative solution for the manufacturing of messenger RNA vaccines and therapies
Meylan, France, July 9, 2025 - Dillico announces [...]
Join our Team – Our Offers
Want to join our team ? May be [...]
National Day of Biomedicine Bioproduction – June 5, 2025.
National Day of Biomedicine Bioproduction – June 5, [...]
Dillico at the 3rd mRNA Process Development & Manufacturing Summit | September 17-19 | Boston, MA, USA
Dillico attended to the 3rd mRNA Process Development [...]
Dillico celebrates a major milestone | September 6 | Meylan, France
On Friday the 6th of September, Dillico celebrated [...]
Dillico to present All-ScaleFlow Technology at MSS2024 Symposium | June 3-7 | Portoroz, Slovenia
Our Chief Development Officer Flora Binder will present [...]
Dillico reveals the design of its continuous manufacturing process equipment for mRNA therapies and vaccines
Dillico reveals the design of its continuous manufacturing [...]
Dillico moved
We are thrilled to announce that we are [...]
All-ScaleFlow™ Technology Presentation at Bioproduction Congress Lyon
The mRNA Revolution: During the pandemic, the implementation [...]
Dillico Grand Prix i-Lab 2023
Dillico Grand Prix i-Lab 2023 (English version below) [...]